Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic
The first Phase II and III clinical trials for treatments for Ebola Virus Disease were conducted during the west Africa (2013-16) outbreak. We report the operational practicalities of conducting a phase II clinical trial of TKM-130803 to international standards during this outbreak.
मुख्य लेखकों: | Rojek, A, Dunning, J, Leliogdowicz, A, Castle, L, Van Lieshout, M, Carson, G, Sahr, F, Olliaro, P, Horby, P |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Oxford University Press
2017
|
समान संसाधन
-
Insights from clinical research completed during the west Africa Ebola virus disease epidemic
द्वारा: Rojek, A, और अन्य
प्रकाशित: (2017) -
Experimental treatment of Ebola virus disease with brincidofovir
द्वारा: Dunning, J, और अन्य
प्रकाशित: (2016) -
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
द्वारा: Rojek, A, और अन्य
प्रकाशित: (2017) -
A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic
द्वारा: Rojek, A, और अन्य
प्रकाशित: (2019) -
Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean patients
द्वारा: Scott, JT, और अन्य
प्रकाशित: (2019)